FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465302180> ?p ?o ?g. }

• W2465302180 endingPage "20765" @default.
• W2465302180 startingPage "20751" @default.
• W2465302180 abstract "// Jie Yi 1, * , Ran Gao 1, * , Yu Chen 1 , Zhuo Yang 1 , Pei Han 3 , Hui Zhang 4 , Yaling Dou 1 , Wenjing Liu 1 , Wengong Wang 3 , Guanhua Du 2 , Yingchun Xu 1 , Jinhua Wang 2 1 Department of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, People’s Republic of China 2 The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China 3 Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, People’s Republic of China 4 Department of Pathology, Peking Union Medical College Hospital, Beijing, People’s Republic of China * These authors have contributed equally to this work Correspondence to: Yingchun Xu, email: xycpumch@139.com Jinhua Wang, email: wjh@imm.ac.cn Keywords: NSUN2, methylation, progression, biomarker, breast cancer Received: March 22, 2016     Accepted: June 06, 2016     Published: November 30, 2016 ABSTRACT NSUN2 is a RNA methyltransferase that has been shown to be implicated in development of human cancer. However, the functional role of NSUN2, mechanism of NSUN2 overexpression and its association with clinicopathologic features in breast cancer remain unclear. To investigate alterations in the expression and functional role of NSUN2 in breast cancer, NSUN2 expression was assessed in breast cancer cells and tissues obtained from cancers at different American Joint Committee on Cancer (AJCC) stages, and its functions were investigated using breast cancer cells. NSUN2 expression was shown to be significantly higher in breast cancer cells and tissues than in normal breast epithelial cells and tissues, at both mRNA and protein levels. Overexpression of NSUN2 was shown to promote cell proliferation, migration, and invasion while NSUN2 knockdown inhibited these processes in vitro and in vivo . NSUN2 expression level was associated with the methylation level of its promoter. Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage ( P =0.027), tumor classification ( P =0.012), pathological differentiation ( P =0.023), as well as with the expression levels of estrogen receptor ( P <0.001), progesterone receptor ( P =0.001), and Ki-67 ( P <0.001). Our findings provide a unique insight into the roles and effects of NSUN2 overexpression in breast cancer cells, and highlight the necessity of the investigation of novel therapeutic targets, such as NSUN2, for the improvement of breast cancer treatments." @default.
• W2465302180 created "2016-07-22" @default.
• W2465302180 creator A5003759585 @default.
• W2465302180 creator A5014066735 @default.
• W2465302180 creator A5014353611 @default.
• W2465302180 creator A5017858894 @default.
• W2465302180 creator A5024076429 @default.
• W2465302180 creator A5025147441 @default.
• W2465302180 creator A5030536674 @default.
• W2465302180 creator A5033681865 @default.
• W2465302180 creator A5034874334 @default.
• W2465302180 creator A5035760212 @default.
• W2465302180 creator A5054922759 @default.
• W2465302180 creator A5090791245 @default.
• W2465302180 date "2016-11-30" @default.
• W2465302180 modified "2023-10-10" @default.
• W2465302180 title "Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer" @default.
• W2465302180 cites W164533244 @default.
• W2465302180 cites W1966319951 @default.
• W2465302180 cites W1970826620 @default.
• W2465302180 cites W1981237473 @default.
• W2465302180 cites W2009270241 @default.
• W2465302180 cites W2010871781 @default.
• W2465302180 cites W2024819383 @default.
• W2465302180 cites W2044702943 @default.
• W2465302180 cites W2051737779 @default.
• W2465302180 cites W2054020671 @default.
• W2465302180 cites W2054211750 @default.
• W2465302180 cites W2055735408 @default.
• W2465302180 cites W2068394634 @default.
• W2465302180 cites W2075380047 @default.
• W2465302180 cites W2081943791 @default.
• W2465302180 cites W2089415609 @default.
• W2465302180 cites W2092030692 @default.
• W2465302180 cites W2102596641 @default.
• W2465302180 cites W2107059185 @default.
• W2465302180 cites W2112894406 @default.
• W2465302180 cites W2121060156 @default.
• W2465302180 cites W2126618982 @default.
• W2465302180 cites W2128347157 @default.
• W2465302180 cites W2131506964 @default.
• W2465302180 cites W2136239966 @default.
• W2465302180 cites W2136582666 @default.
• W2465302180 cites W2139122477 @default.
• W2465302180 cites W2140014485 @default.
• W2465302180 cites W2143356310 @default.
• W2465302180 cites W2144257911 @default.
• W2465302180 cites W2148354075 @default.
• W2465302180 cites W2154413403 @default.
• W2465302180 cites W2161426850 @default.
• W2465302180 cites W2170797683 @default.
• W2465302180 cites W2172336833 @default.
• W2465302180 cites W2259684562 @default.
• W2465302180 cites W2325933796 @default.
• W2465302180 cites W2917837889 @default.
• W2465302180 cites W3190412754 @default.
• W2465302180 cites W4235457469 @default.
• W2465302180 cites W4250969231 @default.
• W2465302180 doi "https://doi.org/10.18632/oncotarget.10612" @default.
• W2465302180 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5400542" @default.
• W2465302180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27447970" @default.
• W2465302180 hasPublicationYear "2016" @default.
• W2465302180 type Work @default.
• W2465302180 sameAs 2465302180 @default.
• W2465302180 citedByCount "71" @default.
• W2465302180 countsByYear W24653021802017 @default.
• W2465302180 countsByYear W24653021802018 @default.
• W2465302180 countsByYear W24653021802019 @default.
• W2465302180 countsByYear W24653021802020 @default.
• W2465302180 countsByYear W24653021802021 @default.
• W2465302180 countsByYear W24653021802022 @default.
• W2465302180 countsByYear W24653021802023 @default.
• W2465302180 crossrefType "journal-article" @default.
• W2465302180 hasAuthorship W2465302180A5003759585 @default.
• W2465302180 hasAuthorship W2465302180A5014066735 @default.
• W2465302180 hasAuthorship W2465302180A5014353611 @default.
• W2465302180 hasAuthorship W2465302180A5017858894 @default.
• W2465302180 hasAuthorship W2465302180A5024076429 @default.
• W2465302180 hasAuthorship W2465302180A5025147441 @default.
• W2465302180 hasAuthorship W2465302180A5030536674 @default.
• W2465302180 hasAuthorship W2465302180A5033681865 @default.
• W2465302180 hasAuthorship W2465302180A5034874334 @default.
• W2465302180 hasAuthorship W2465302180A5035760212 @default.
• W2465302180 hasAuthorship W2465302180A5054922759 @default.
• W2465302180 hasAuthorship W2465302180A5090791245 @default.
• W2465302180 hasBestOaLocation W24653021801 @default.
• W2465302180 hasConcept C105639569 @default.
• W2465302180 hasConcept C121608353 @default.
• W2465302180 hasConcept C126322002 @default.
• W2465302180 hasConcept C143998085 @default.
• W2465302180 hasConcept C144133560 @default.
• W2465302180 hasConcept C17744445 @default.
• W2465302180 hasConcept C191935318 @default.
• W2465302180 hasConcept C199539241 @default.
• W2465302180 hasConcept C2778304055 @default.
• W2465302180 hasConcept C2910001868 @default.
• W2465302180 hasConcept C530470458 @default.
• W2465302180 hasConcept C556039675 @default.

• next